Celltrion Group has recently announced that the company has successfully selected the most potent antibody candidates to neutralize SARS-CoV-2, the virus causing COVID-19.  Through its partnership with Korea’s Centers for Disease Control and… read more

Samsung Biologics and ImmuneOncia Therapeutics has received US Food and Drug Authority, Investigational New Drug’s (FDA IND) approval of its inhibitor antibody, IMC-002.    According to the development and manufacturing agreement between two… read more

Calling for your Opinions: How can Developing Countries react quicker to Pandemic Outbreaks? At the recent Vaccines World Summit in Pune, India, a key topic of discussion was "How can Developing Countries react quicker… read more

MicrofluidX, a pharmaceutical technology provider has raised over $1.7 million to help develop its cell bioprocessing technology. This newly acquired fund will be used to develop a working prototype of its bioprocessing platform… read more

Two BIG Pharma, GlaxoSmithKline (GSK) and Sanofi has recently announced its agreement into developing an adjuvanted vaccine against COVID-19. Both companies expect to begin Phase I clinical trials in the latter half of… read more

Biocon’s two manufacturing sites in Bangalore, India were inspected back in September 2019 by the US Food and Drug Administration (also known as FDA).    The two manufacturing facilities are used to manufacture… read more

Pharmaceutical giant, Takeda hopes to strengthen its early-stage gene therapies in its pipelines through a long–term research agreement with Evotec GT. Takeda has numerous early-stage assets under its belt especially after recently acquiring… read more

Researchers have discovered a new CAR T-cell therapy that targets three proteins on leukemia cells and has shown success in pre-clinical trials. read more

Researchers from the University of Connecticut, School of Dental Medicine in the United States have discovered that a population of stem cells can generate a new bone. The researchers present a new population… read more

Johnson & Johnson said that they will begin on developing and manufacturing a new coronavirus vaccine with the U.S. government, after seizing over $1 billion deal with them.   They would be working… read more